Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
In this NEJM Double Take episode, experts discuss the critical role of neuroplasticity in depression and examine advanced treatment options for patients who do not respond to traditional therapies. Topics include the efficacy of ECT and TMS, as well as emerging evidence for ketamine, esketamine, and psilocybin.
Psychiatry June 4th 2024
Psychiatry Advisor
Recent studies indicate that while ketamine and ECT are equally effective for treating MDD, ketamine did not prove non-inferior to ECT for MDEs. Both treatments have distinct side effect profiles that are critical for clinical decision-making.
Psychiatry May 21st 2024
MDLinx
Recent studies highlight that while meditation is beneficial for many, it can also lead to significant mental health challenges, including anxiety, psychosis, and depersonalization, particularly in intense meditative practices.
Psychiatry May 14th 2024
Healthgrades for Professionals
Vicks VapoRub, a staple in cold treatment, also shows promise in dermatological and pain relief applications. Its efficacy in treating toenail fungus and potential in softening skin highlights its versatility in patient care.
All Specialties March 13th 2024
Neurology Advisor
Explore the potential of tDCS as a non-pharmacological intervention for Alzheimer’s disease, demonstrating significant cognitive improvements linked to enhanced cortical plasticity, without serious adverse effects.
Neurology March 5th 2024
Consultant360
In this video, Dr. Charles Raison reveals how hyperthermia may harness the body’s immune response to combat major depressive disorder, suggesting a potential shift in non-pharmacological treatment strategies.
Psychiatry February 13th 2024